Newsletter
N°1
May 2009
   
FibroMeters, liver fibrosis and steatosis diagnosis in EASL 2009
 
 
Diagnosis of liver fibrosis
The combination blood test + ultrasonographic elastometry improves the diagnostic performance of liver fibrosis and decreases the requirement in liver biopsy.

Thus, the combination Fibroscan and FibroMeter is the most performant: it significantly increases the diagnostic accuracy and even the predictive values. (J Boursier et al., P 180)
NLA1D1.PNG

See the presentation

Quantitative evaluation of fibrosis progression in chronic liver diseases.

The progression rate of liver fibrosis was similar between viral and alcoholic chronic liver diseases when the beginning of the disease was taken into account. This progression rate was predicted by blood test with a good accuracy.
(P Calès et al., P 737)

NLA1D2.PNG 

See the presentation
   
Diagnosis of liver steatosis
Histological and non-invasive quantification of liver steatosis.

It is now possible to precisely measure liver steatosis thanks to a fully automated, objective and very reproducible method though the area of steatosis. This area of steatosis can be accurately predicted by a new MRI sequence or blood variables or both.
(E. Cesbron, J Boursier et al.,P 697 & 983)
NLA1D3.PNG
 
Practical aspects
How to perform FibroMeters

More informations at www.biols.com or by phone at +33 (0)2.41.36.07.19
 
 
BioLiveScale Faculté de médecine - Rue Haute de Reculée - 49045 Angers Cedex France - www.biols.com
Aller sur le site de BioLiveScale